GEN Exclusives

More »

GEN News Highlights

More »
Apr 15, 2010

Thermo Fisher Scientific to Purchase Proxeon for Proteomics Workflow Solutions

  • Thermo Fisher Scientific has acquired Proxeon, a supplier of products for proteomics analysis headquartered in Odense, Denmark. Thermo Fisher Scientific says that Proxeon provides a simplified proteomics workflow including nanoflow liquid chromatography systems, columns, ion sources, and bioinformatics software to meet the need for robust high-sensitivity LC/MS analysis in complex proteomics applications.

    Proxeon had revenues of approximately $10 million in 2009, according to Thermo Fisher Scientific. It will be integrated into Thermo Fisher’s analytical technologies segment. The company does not expect this transaction to have a material impact on its 2010 financial results.

    Proxeon’s nanoflow liquid chromatography system, EASY-nLC, features an intuitive graphical user interface, touch-screen operation, and remote diagnostics capability. It includes an autosampler, which allows reproducible low-nanoliter injections into the mass spectrometer. The system also provides two-dimensional chromatographic capability to identify more proteins than conventional methods without the increased complexity of added valves and pumps, according to Proxeon.

    “By offering a high-performance solution that addresses the need for simplified operation, we can meet the increasing demand for LC/MS in proteomics applications,” says Marc N. Casper, president and CEO of Thermo Fisher Scientific. “These systems can be easily integrated with our leading ion trap, hybrid, and triple quadrupole mass spectrometry systems, in line with our strategy of providing comprehensive LC/MS solutions for both high-end research and routine applications.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?